Nyxoah SA (NYXH) vs Stereotaxis Inc. (STXS)

Nyxoah SA and Stereotaxis Inc. are both Medical Instruments & Supplies companies. Nyxoah SA and Stereotaxis Inc. are of similar size ($133.3M and $129.3M). Nyxoah SA grew revenue faster over the last twelve months: 366.2% against −5.46%. Stereotaxis Inc. has the higher net margin (−78.5% vs −446.4%) and the lower return on invested capital (−203.6% vs −117.8%). Across the 18 metrics below, Nyxoah SA leads on 10 and Stereotaxis Inc. on 8.

Valuation

Metric NYXH STXS Medical Instruments & Supplies median
P/E n/m n/m 34.17
P/S 3.30 4.32 2.83
P/B 0.86 10.62 2.82
Price to free cash flow n/m n/m 25.69
EV/EBITDA n/m n/m 16.08
EV/Sales 1.52 4.16 3.06
Earnings yield (173.79%) (18.46%) (1.84%)
Free cash flow yield (104.64%) (11.92%) 0.17%

Profitability

Metric NYXH STXS Medical Instruments & Supplies median
Gross margin 60.16% 55.57% 54.62%
Operating margin (391.25%) (75.68%) 1.64%
Net margin (446.39%) (78.45%) 0.00%
Free cash flow margin (344.99%) (51.56%) 1.61%
Return on equity (124.41%) (344.36%) 0.00%
Return on assets (68.23%) (48.76%) 0.00%
Return on invested capital (117.82%) (203.58%) 0.00%

Growth

Metric NYXH STXS Medical Instruments & Supplies median
Revenue growth (TTM) 366.24% (5.46%) 9.20%
EPS growth (last fiscal year) (36.22%) 16.67% —
Revenue growth, 5-year CAGR 170.14% 3.99% 9.48%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric NYXH STXS Medical Instruments & Supplies median
Debt to equity 0.72 0.00 0.08
Current ratio 2.38 1.42 2.49
Net debt to EBITDA 0.08 0.65 0.83

Dividend

Metric NYXH STXS Medical Instruments & Supplies median
Dividend yield — — 0.99%
Payout ratio 0.00 0.00 0.00

Size

Metric NYXH STXS Medical Instruments & Supplies median
Market cap 129.34m 133.27m 938.39m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack